Evidence map›Paper›PMID 40184266›Full record

ArticleJournal of proteome research2025

metLinkR: Facilitating Metaanalysis of Human Metabolomics Data through Automated Linking of Metabolite Identifiers.

Andrew Patt, Iris Pang, Fred Lee, Chiraag Gohel, Eoin Fahy, Vicki Stevens, David Ruggieri, Steven C Moore, Ewy A Mathé

Abstract read
In one paragraph

Article in Journal of proteome research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Andrew PattDivision of Preclinical Innovation, National Center for Advancing Translational Sciences, NIH, Rockville, Maryland 20892, United States.ORCID 0000-0002-6373-9545
Iris PangDivision of Preclinical Innovation, National Center for Advancing Translational Sciences, NIH, Rockville, Maryland 20892, United States.
Fred LeeDivision of Preclinical Innovation, National Center for Advancing Translational Sciences, NIH, Rockville, Maryland 20892, United States.ORCID 0009-0006-0572-6742
Chiraag GohelDepartment of Biostatistics and Bioinformatics, George Washington University, Washington, District of Columbia 20052, United States.
Eoin FahyDepartment of Bioengineering, University of California San Diego, La Jolla, California 92092, United States.
Vicki StevensDivision of Preclinical Innovation, National Center for Advancing Translational Sciences, NIH, Rockville, Maryland 20892, United States.
David RuggieriDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland 20892, United States.
Steven C MooreDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland 20892, United States.
Ewy A MathéDivision of Preclinical Innovation, National Center for Advancing Translational Sciences, NIH, Rockville, Maryland 20892, United States.ORCID 0000-0003-4491-8107

Funding

Informatics Research CoreZICTR000410 · NCATS · NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES · PI MATHÉ, EWY · 2021 to 2025
$11.7M
Metabolomics Workbench - National Metabolomics Data RepositoryU24DK141185 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Shankar Subramaniam · 2024 to 2026
$4.2M
Intramural NIH HHS ZIC TR000410NIDDK NIH HHS U24 DK141185
6 · The paper itself

Abstract

Metabolites are referenced in spectral, structural and pathway databases with a diverse array of schemas, including various internal database identifiers and large tables of common name synonyms. Cross-linking metabolite identifiers is a required step for meta-analysis of metabolomic results across studies but made difficult due to the lack of a consensus identifier system. We have implemented metLinkR, an R package that leverages RefMet and RaMP-DB to automate and simplify cross-linking metabolite identifiers across studies and generating common names. MetLinkR accepts as input metabolite common names and identifiers from five different databases (HMDB, KEGG, ChEBI, LIPIDMAPS and PubChem) to exhaustively search for possible overlap in supplied metabolites from input data sets. In an example of 13 metabolomic data sets totaling 10,400 metabolites, metLinkR identified and provided common names for 1377 metabolites in common between at least 2 data sets in less than 18 min and produced standardized names for 74.4% of the input metabolites. In another example comprising five data sets with 3512 metabolites, metLinkR identified 715 metabolites in common between at least two data sets in under 12 min and produced standardized names for 82.3% of the input metabolites. Outputs of MetLInR include output tables and metrics allowing users to readily double check the mappings and to get an overview of chemical classes represented. Overall, MetLinkR provides a streamlined solution for a common task in metabolomic epidemiology and other fields that meta-analyze metabolomic data. The R package, vignette and source code are freely downloadable at https://github.com/ncats/metLinkR.

Indexed as

MetabolomeMetabolomicsSoftwareDatabases, FactualHumansMeta-Analysis as Topicdatabaseslipidomicsmetabolomics

Identifiers

PMID40184266
PMCPMC12053952

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.